Keith W. Pfeil's most recent trade in Globus Medical Inc - Ordinary Shares - Class A was a trade of 100,000 Stock Option (Right to Buy Class A Common Stock) done . Disclosure was reported to the exchange on Jan. 21, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Globus Medical Inc (Class A) | Keith W. Pfeil | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2026 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | Keith W. Pfeil | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | Keith W. Pfeil | COO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | Keith W. Pfeil | COO, CFO | Sale of securities on an exchange or to another person at price $ 88.17 per share. | 10 Jan 2025 | 12,501 | 1,666 (0%) | 0% | 88.2 | 1,102,213 | Class A Common Stock |
| Globus Medical Inc (Class A) | Keith W. Pfeil | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.27 per share. | 10 Jan 2025 | 8,334 | 14,167 (0%) | 0% | 53.3 | 443,952 | Class A Common Stock |
| Globus Medical Inc (Class A) | Keith W. Pfeil | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2025 | 8,334 | 833 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | Keith W. Pfeil | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.65 per share. | 10 Jan 2025 | 5,833 | 5,833 (0%) | 0% | 49.6 | 289,608 | Class A Common Stock |
| Globus Medical Inc (Class A) | Keith W. Pfeil | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2025 | 5,833 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | Keith W. Pfeil | COO, CFO | Sale of securities on an exchange or to another person at price $ 89.17 per share. | 10 Jan 2025 | 1,666 | 0 (0%) | 0% | 89.2 | 148,557 | Class A Common Stock |
| Globus Medical Inc (Class A) | W. Keith Pfeil | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | Keith W. Pfeil | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2023 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | Keith W. Pfeil | SVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 77.57 per share. | 02 Feb 2023 | 29,167 | 0 (0%) | 0% | 77.6 | 2,262,426 | Class A Common Stock |
| Globus Medical Inc (Class A) | Keith W. Pfeil | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 15,000 | 9,167 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | Keith W. Pfeil | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.27 per share. | 02 Feb 2023 | 15,000 | 29,167 (0%) | 0% | 53.3 | 799,050 | Class A Common Stock |
| Globus Medical Inc (Class A) | Keith W. Pfeil | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 14,167 | 5,833 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | Keith W. Pfeil | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.65 per share. | 02 Feb 2023 | 14,167 | 14,167 (0%) | 0% | 49.7 | 703,392 | Class A Common Stock |
| Globus Medical Inc (Class A) | Keith W. Pfeil | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | Keith W. Pfeil | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | Keith W. Pfeil | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2021 | 833 | 20,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | Keith W. Pfeil | SVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 76.13 per share. | 19 Aug 2021 | 833 | 0 (0%) | 0% | 76.1 | 63,416 | Class A Common Stock |
| Globus Medical Inc (Class A) | Keith W. Pfeil | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.65 per share. | 19 Aug 2021 | 833 | 833 (0%) | 0% | 49.6 | 41,358 | Class A Common Stock |
| Globus Medical Inc (Class A) | Keith W. Pfeil | SVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 83.24 per share. | 02 Aug 2021 | 833 | 0 (0%) | 0% | 83.2 | 69,339 | Class A Common Stock |
| Globus Medical Inc (Class A) | Keith W. Pfeil | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 833 | 24,167 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | Keith W. Pfeil | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.27 per share. | 02 Aug 2021 | 833 | 833 (0%) | 0% | 53.3 | 44,374 | Class A Common Stock |